✦ LIBER ✦

Safety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignancies

✍ Scribed by Razelle Kurzrock; Sanjay Goel; Jennifer Wheler; David Hong; Siqing Fu; Keyvan Rezai; Sonia K. Morgan-Linnell; Saik Urien; Sridhar Mani; Imran Chaudhary; Mohammed H. Ghalib; Aby Buchbinder; François Lokiec; Mary Mulcahy

Book ID: 112067226
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 458 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.27647

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I dose-escalation study of EZN-220

Phase I dose-escalation study of EZN-2208 (PEG-SN38), a novel conjugate of poly(ethylene) glycol and SN38, administered weekly in patients with advanced cancer

✍ Amita Patnaik, Kyriakos P. Papadopoulos… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 256 KB

427 POSTER Pharmacokinetics (PK) of EZN-

427 POSTER Pharmacokinetics (PK) of EZN-2208, a novel anticancer agent, in patients (pts) with advanced malignancies: a phase I dose-escalation study

✍ A. Patnaik; M. Goldston; C. Takimoto; A. Tolcher; K. Papadopoulos; T. Bekaii-Saa 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Safety and pharmacokinetics of novel sel

Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies

✍ Jin Li; Xinmin Zhao; Lei Chen; Haiyi Guo; Fangfang Lv; Ka Jia; Ke Yv; Fengqing W 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 547 KB

Pharmacokinetics and safety of ILX23-755

Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3analogue, in a phase I study of patients with advanced malignancies

✍ Robert Wieder; Steven C. Novick; Bruce W. Hollis; Margarette Bryan; Suzanne M. C 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 270 KB

A Phase 1 Dose Escalation Study of the S

A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of the Novel Proteasome Inhibitor Carfilzomib (PR-171) in Patients with Hematologic Malignancies

✍ O'Connor, O. A.; Stewart, A. K.; Vallone, M.; Molineaux, C. J.; Kunkel, L. A.; G 📂 Article 📅 2009 🏛 American Association for Cancer Research 🌐 English ⚖ 377 KB

Pharmacokinetics and Safety of Bortezomi

Pharmacokinetics and Safety of Bortezomib in Patients with Advanced Malignancies and Varying Degrees of Liver Dysfunction: Phase I NCI Organ Dysfunction Working Group Study NCI-6432

✍ LoRusso, P. M.; Venkatakrishnan, K.; Ramanathan, R. K.; Sarantopoulos, J.; Mulke 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 535 KB